Valneva SE VALN

Latest FY: 2025 Healthcare Biotechnology
Market Price $7.07
Market Cap $1.23B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑3.0% YoY
$174.66M
3-Yr CAGR: -21.5%
Net Income ↓-893.5% YoY
-$114.12M
Net Margin: -65.3%
Free Cash Flow ↑82.0% YoY
-$2.22M
FCF Yield: -0.18%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
-107.5%
ROA: -28.6%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (VALN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2019 $126.2M $73.4M $-0.9M $-2.3M $-12.8M
FY 2020 $110.3M -12.6% $56.0M $-65.3M -7,406.0% $2.0M $-16.9M -31.7%
FY 2021 $348.1M +215.5% $160.2M $-70.0M -7.2% 0.00% $1.6M $-90.6M -435.6%
FY 2022 $361.3M +3.8% $36.9M $-144.8M -106.9% 0.00% $0.2M $-29.1M +67.9%
FY 2023 $153.7M -57.5% $52.8M $-98.6M +31.9% 0.00% $1.2M $-13.0M +55.3%
FY 2024 $169.6M +10.3% $71.0M $-11.5M +88.4% 0.00% $1.5M $-12.3M +5.2%
FY 2025 $174.7M +3.0% $67.5M $-114.1M -893.5% 0.00% $2.2M $-2.2M +82.0%
$

Valuation

Market Price $7.07
Market Cap $1.23B
Enterprise Value $1.32B
P/E Ratio N/A
P/B Ratio 11.56
FCF Yield -0.18%
Dividend Yield 0.00%
Shares Outstanding 173,539,745
%

Profitability & Margins

Gross Margin 38.66%
Operating Margin -46.98%
Net Margin -65.34%
Return on Equity (ROE) -107.49%
Return on Assets (ROA) -28.61%
Asset Turnover 0.44x
Revenue 3-Yr CAGR -21.52%
🛡️

Financial Health & Liquidity

Current Ratio 2.38
Cash Ratio 1.17
Debt / Equity 1.952
Debt / Assets 0.520
Cash & Equivalents $109.65M
Total Debt $207.25M
Book Value / Share $0.61
💧

Cash Flow Efficiency

Operating Cash Flow $2.20M
Capital Expenditures (CapEx) $4.42M
Free Cash Flow -$2.22M
OCF / Revenue 1.26%
FCF / Revenue -1.27%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $0.61
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $398.84M
Total Liabilities $292.67M
Stockholders' Equity $106.17M
Current Assets $222.54M
Current Liabilities $93.33M